Affichage de 1017 résultats

Description archivistique
Ernest Armstrong McCulloch fonds
Aperçu avant impression Affichage :
Ernest Armstrong McCulloch fonds
Ernest Armstrong McCulloch fonds
Long term curing: Annex Mouse Production Charts; Mouse Production Charts
Long term curing: Annex Mouse Production Charts; Mouse Production Charts
Miscellaneous Experiments; Friend Virus (RFVI, TFVI,FV2, RFV experiments); Worksheets
Miscellaneous Experiments; Friend Virus (RFVI, TFVI,FV2, RFV experiments); Worksheets
AML blast cell experiments: effects of Ara-C and Cistplatin, vol. 1 (1)
AML blast cell experiments: effects of Ara-C and Cistplatin, vol. 1 (1)
AML blast cell experiments: effects ofAra-C and Cistplatin, vol. 1 (2)
AML blast cell experiments: effects ofAra-C and Cistplatin, vol. 1 (2)
ML blast cell experiments: titration of irridated cells (normal and abnormal) Experiments Mc161 - Mc175
ML blast cell experiments: titration of irridated cells (normal and abnormal) Experiments Mc161 - Mc175
AML blast cell experiments: Radiation survival
AML blast cell experiments: Radiation survival
AML blast cell experiments: effects of Ara-C and Cistplatin, vol. 2
AML blast cell experiments: effects of Ara-C and Cistplatin, vol. 2
AML blast cell experiments: Normal B.M.; Experiments Mc71 - Mc105
AML blast cell experiments: Normal B.M.; Experiments Mc71 - Mc105
AML blast cell experiments (Maguire) Experiments Mc60 - Mc198
AML blast cell experiments (Maguire) Experiments Mc60 - Mc198
AML blast cell experiments: Steward; Experiments Mc164 - Mc213
AML blast cell experiments: Steward; Experiments Mc164 - Mc213
AML patients--alphabetical (6): L-M
AML patients--alphabetical (6): L-M
AML patients--alphabetical (8): P
AML patients--alphabetical (8): P
AML patients--alphabetical (7): Mc-O
AML patients--alphabetical (7): Mc-O
AML patients--alphabetical (10): S
AML patients--alphabetical (10): S
AML patients--alphabetical (11): T-Z
AML patients--alphabetical (11): T-Z
AML patients--alphabetical (5): H-K
AML patients--alphabetical (5): H-K
AML patients--alphabetical (9): R
AML patients--alphabetical (9): R
AML patients--alphabetical (2): B
AML patients--alphabetical (2): B
AML patients--alphabetical (3): C
AML patients--alphabetical (3): C
AML patients--alphabetical (4): D-G
AML patients--alphabetical (4): D-G
AML data [New Series] (2): H-P
AML data [New Series] (2): H-P
AML data [New Series] (1): A-F
AML data [New Series] (1): A-F
AML patients--alphabetical (1): A
AML patients--alphabetical (1): A
AML data [New Series] (3): S-Y
AML data [New Series] (3): S-Y
Volume: VV (repression) experiments - Connie (3); VV281-VV314
Volume: VV (repression) experiments - Connie (3); VV281-VV314
Early experiments on AML blast cells (2) Dewell; Schafer; Cherubini; Ciafuarella; Rhody
Early experiments on AML blast cells (2) Dewell; Schafer; Cherubini; Ciafuarella; Rhody
Volume: VV (repression) experiments (1): ASP1-ASP6; Table of contents for VV experiments; VV332-VV338; VV340, VV341, VV343; VV344, VV346-VV349
Volume: VV (repression) experiments (1): ASP1-ASP6; Table of contents for VV experiments; VV332-VV338; VV340, VV341, VV343; VV344, VV346-VV349
Volume: VV (repression) experiments (2); VV350-VV384
Volume: VV (repression) experiments (2); VV350-VV384
Volume: VV (repression) experiments - Connie (4); VV315-VV334
Volume: VV (repression) experiments - Connie (4); VV315-VV334
V-1 to V-36[effect of vinblastime sulphate]; V-V1 to V-V159 [experiments to compare; survival of CFU-S and CFU-A incubated in vitro]
V-1 to V-36[effect of vinblastime sulphate]; V-V1 to V-V159 [experiments to compare; survival of CFU-S and CFU-A incubated in vitro]
V-V160 to V-V219; ,Z, FQ and Q; RB - CD
V-V160 to V-V219; ,Z, FQ and Q; RB - CD
Early experiments on AML blast cells (1): Clements; Cote; Cupello
Early experiments on AML blast cells (1): Clements; Cote; Cupello
Volume: SC, D and E experiments (1): SC18, SC21, SC23-SC32; SC34-SC38, SC40-SC42; RASAB11-RASAB 14; MA1
Volume: SC, D and E experiments (1): SC18, SC21, SC23-SC32; SC34-SC38, SC40-SC42; RASAB11-RASAB 14; MA1
Volume: VV experiments (1); VV100-VV115
Volume: VV experiments (1); VV100-VV115
Volume: VV (repression) experiments - Connie (1); VV220-VV238, VV240-VV252
Volume: VV (repression) experiments - Connie (1); VV220-VV238, VV240-VV252
Volume: SC, D and E experiments (2): D1-D46; E1-E3; F1-F5
Volume: SC, D and E experiments (2): D1-D46; E1-E3; F1-F5
Volume: SPL/SPR experiments -CRU experiments on the spleen; SPL1-SPL5; SPR
Volume: SPL/SPR experiments -CRU experiments on the spleen; SPL1-SPL5; SPR
Volume: VV experiments (1); VV84-VV99
Volume: VV experiments (1); VV84-VV99
Volume: VV experiments (3); VV116-VV129
Volume: VV experiments (3); VV116-VV129
Volume: VV (repression) experiments - Connie (2); VV253-VV280
Volume: VV (repression) experiments - Connie (2); VV253-VV280
NA20, NA21, NA23, NA28, NA33-NA39, NA41, NA42, NA44-NA49, NA53-NA63
NA20, NA21, NA23, NA28, NA33-NA39, NA41, NA42, NA44-NA49, NA53-NA63
Volume: PG (2): PG39-PG63
Volume: PG (2): PG39-PG63
Volume: R experiments: R19263, R26363, R27363, R15463; R8563, H24362, R21163, R19663
Volume: R experiments: R19263, R26363, R27363, R15463; R8563, H24362, R21163, R19663
Volume: SC experiments (1): Table of contents; SC3-SC22
Volume: SC experiments (1): Table of contents; SC3-SC22
Volume: SC experiments (2); SC23-SC37, SC40, SC41
Volume: SC experiments (2); SC23-SC37, SC40, SC41
Volume: PG (3): PG64-PG82, PG84-PG86
Volume: PG (3): PG64-PG82, PG84-PG86
Volume: PF experiments: PF7-PF10, PF12-PF28, PF30-PF37
Volume: PF experiments: PF7-PF10, PF12-PF28, PF30-PF37
Volume: PG (1): PG1-PG38
Volume: PG (1): PG1-PG38
K1 to K18; MC; MLV1 to 3; MY; HB; N1 to N17;
K1 to K18; MC; MLV1 to 3; MY; HB; N1 to N17;
Résultats 1 à 50 sur 1017